Kodiak Sciences Stock Performance
| KOD Stock | USD 3.64 0.19 5.51% |
The company secures a Beta (Market Risk) of 1.98, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Kodiak Sciences will likely underperform. At this point, Kodiak Sciences has a negative expected return of -1.3%. Please make sure to verify Kodiak Sciences' potential upside, and the relationship between the total risk alpha and daily balance of power , to decide if Kodiak Sciences performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Kodiak Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders. ...more
Actual Historical Performance (%)
One Day Return 5.51 | Five Day Return 2.82 | Year To Date Return (57.77) | Ten Year Return 79.31 | All Time Return 79.31 |
1 | Acquisition by Profusek Robert of 40000 shares of Kodiak Sciences at 2.35 subject to Rule 16b-3 | 12/24/2024 |
2 | Kodiak Sciences to Present at 43rd Annual J.P. Morgan Healthcare Conference | 01/07/2025 |
3 | Acquisition by Baker Bros. Advisors Lp of 42250 shares of Kodiak Sciences at 6.6036 subject to Rule 16b-3 | 01/22/2025 |
4 | Kodiak Sciences Inc. Sees Large Increase in Short Interest - MarketBeat | 02/07/2025 |
5 | Acquisition by Ehrlich Jason of 5494 shares of Kodiak Sciences subject to Rule 16b-3 | 02/24/2025 |
6 | Were Keeping An Eye On Kodiak Sciences Cash Burn Rate | 02/25/2025 |
7 | Acquisition by Baker Bros. Advisors Lp of 116 shares of Kodiak Sciences at 6.755 subject to Rule 16b-3 | 02/28/2025 |
8 | Acquisition by Borgeson John A. of 5494 shares of Kodiak Sciences subject to Rule 16b-3 | 03/07/2025 |
9 | Acquisition by Perlroth Victor of 325000 shares of Kodiak Sciences subject to Rule 16b-3 | 03/14/2025 |
| Begin Period Cash Flow | 190.4 M |
Kodiak |
Kodiak Sciences Relative Risk vs. Return Landscape
If you would invest 887.00 in Kodiak Sciences on December 17, 2024 and sell it today you would lose (523.00) from holding Kodiak Sciences or give up 58.96% of portfolio value over 90 days. Kodiak Sciences is generating negative expected returns assuming volatility of 5.912% on return distribution over 90 days investment horizon. In other words, 52% of stocks are less volatile than Kodiak, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Kodiak Sciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Kodiak Sciences' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Kodiak Sciences, and traders can use it to determine the average amount a Kodiak Sciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.2202
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | KOD |
Estimated Market Risk
| 5.91 actual daily | 52 52% of assets are less volatile |
Expected Return
| -1.3 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.22 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Kodiak Sciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Kodiak Sciences by adding Kodiak Sciences to a well-diversified portfolio.
Kodiak Sciences Fundamentals Growth
Kodiak Stock prices reflect investors' perceptions of the future prospects and financial health of Kodiak Sciences, and Kodiak Sciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Kodiak Stock performance.
| Return On Equity | -0.79 | ||||
| Return On Asset | -0.28 | ||||
| Current Valuation | 66.07 M | ||||
| Shares Outstanding | 52.62 M | ||||
| Price To Earning | (2.29) X | ||||
| Price To Book | 1.03 X | ||||
| EBITDA | (259.02 M) | ||||
| Net Income | (260.49 M) | ||||
| Cash And Equivalents | 597.88 M | ||||
| Cash Per Share | 11.55 X | ||||
| Total Debt | 81.63 M | ||||
| Debt To Equity | 0.16 % | ||||
| Current Ratio | 8.65 X | ||||
| Book Value Per Share | 3.53 X | ||||
| Cash Flow From Operations | (154.18 M) | ||||
| Earnings Per Share | (3.64) X | ||||
| Market Capitalization | 191.55 M | ||||
| Total Asset | 479.37 M | ||||
| Retained Earnings | (1.15 B) | ||||
| Working Capital | 247.58 M | ||||
| Current Asset | 7.31 M | ||||
| Current Liabilities | 4.89 M | ||||
About Kodiak Sciences Performance
By analyzing Kodiak Sciences' fundamental ratios, stakeholders can gain valuable insights into Kodiak Sciences' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Kodiak Sciences has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Kodiak Sciences has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.49) | (0.51) | |
| Return On Capital Employed | (0.73) | (0.69) | |
| Return On Assets | (0.49) | (0.51) | |
| Return On Equity | (1.13) | (1.07) |
Things to note about Kodiak Sciences performance evaluation
Checking the ongoing alerts about Kodiak Sciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Kodiak Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Kodiak Sciences generated a negative expected return over the last 90 days | |
| Kodiak Sciences has high historical volatility and very poor performance | |
| Kodiak Sciences has high likelihood to experience some financial distress in the next 2 years | |
| Reported Net Loss for the year was (260.49 M) with profit before taxes, overhead, and interest of 0. | |
| Kodiak Sciences has about 597.88 M in cash with (154.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 11.55, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Kodiak Sciences has a frail financial position based on the latest SEC disclosures | |
| Over 80.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Were Keeping An Eye On Kodiak Sciences Cash Burn Rate |
- Analyzing Kodiak Sciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Kodiak Sciences' stock is overvalued or undervalued compared to its peers.
- Examining Kodiak Sciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Kodiak Sciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Kodiak Sciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Kodiak Sciences' stock. These opinions can provide insight into Kodiak Sciences' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Kodiak Stock analysis
When running Kodiak Sciences' price analysis, check to measure Kodiak Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kodiak Sciences is operating at the current time. Most of Kodiak Sciences' value examination focuses on studying past and present price action to predict the probability of Kodiak Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kodiak Sciences' price. Additionally, you may evaluate how the addition of Kodiak Sciences to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |